Background: cardiomyopathies include a broad spectrum of myocardial problems which can affect the heart either a primary disease process or as part of a systemic disorder, which may be complicated by heart failure or death. Objective: the aim of the study to identify the role of cardiac magnetic resonance imaging to diagnose the different various types of cardiomyopathy. Patients and Methods: this study included 50 patients with suspected different types of non-ischemic cardiomyopathies referred from outpatient clinic of Cardiology at Al-Hussein University hospital from November 2018 to July 2019. Results: all patients showed mild to moderate mitral regurge (100% of cases), tricuspid regurge was seen in 3 cases (75% of cases) and aortic regurge was seen in 4 cases (50% of cases). The most value of MRI study of these patients was to differentiate whether if heart failure is related to 1ry dilated cardiomyopathy or other causes such as ischemia as they have different management in each group. Conclusion: CMR is a valuable (minimally or non-invasive) imaging technique in patients with suspected or known to have non-ischemic cardiomyopathies. It helps to identify the underlying cause, prognosis and responsiveness to therapy and affect management as well follow-up and most recently as a preventive diagnostic tool.
Published in | International Journal of Medical Imaging (Volume 9, Issue 1) |
DOI | 10.11648/j.ijmi.20210901.17 |
Page(s) | 72-78 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2021. Published by Science Publishing Group |
MRI, CMR, Ischemic Cardiomyopathy
[1] | O'Neill AC, McDermott S, Ridge CA et al. (2012): Investigation of cardiomyopathy using cardiac magnetic resonance imaging part 2: Rare phenotypes. World J Cardiol., 4 (5): 173-82. |
[2] | Bogaert J and Dymarkowski S (2012): Ischemic Heart. In: Clinical Cardiac MRI, Bogaert, J., S. Dymarkowski, A. M. Taylor and V. Muthurangu (Eds.), Springer, New York, Pp. 227-231. |
[3] | Hinojar R, Foote L, Sangle S et al. (2016): Native T1 and T2 mapping by CMR in lupus myocarditis: Disease recognition and response to treatment. International Journal of Cardiology, 222: 717–26. |
[4] | Chan RH, Maron BJ, Olivotto I et al. (2014): Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. Circulation, 130: 484–95. |
[5] | Coleman GC, Shaw PW, Balfour PC et al. (2017): Prognostic Value of Myocardial Scarring on CMR in Patients With Cardiac Sarcoidosis. JACC Cardiovascular Imaging, 10: 411–420. |
[6] | White JA, Kim HW, Shah D et al. (2014): CMR imaging with rapid visual T1 assessment predicts mortality in patients suspected of cardiac amyloidosis. JACC Cardiovascular Imaging, 7: 143–56. |
[7] | McLellan A, Ellims AH, Prabhu S et al. (2016): Diffuse ventricular fibrosis on cardiac magnetic resonance imaging associates with ventricular tachycardia in patients with hypertrophic cardiomyopathy. Journal of Cardiovascular Electrophysiology, 27: 571–80. |
[8] | Gulati A, Jabbour A, Ismail TF et al. (2013): Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. Jama., 309: 896–908. |
[9] | Jacquier A, Thuny F, Jop B et al. (2010): Measurement of trabeculated left ventricular mass using cardiac magnetic resonance imaging in the diagnosis of left ventricular non- compaction. European Heart Journal, 31: 1098–104. |
[10] | McKenna WJ, Desai MY, Ommen SR et al. (1994): Imaging phenotype versus genotype in hypertrophic cardiomyopathy. Circ Cardiovasc Imaging, 4: 156–68. |
[11] | Birnie DH, Sauer WH, Bogun Fet al. (2014): HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm, 11: 1305–23. |
[12] | Kramer CM, Appelbaum E, Desai MY et al. (2015): Hypertrophic Cardiomyopathy Registry: The rationale and design of an international, observational study of hypertrophic cardiomyopathy. American Heart Journal, 170: 223–30. |
[13] | Schieda N, Blaichman JI, Costa AF et al. (2018): Gadolinium-Based Contrast Agents in Kidney Disease: A Comprehensive Review and Clinical Practice Guideline Issued by the Canadian Association of Radiologists. Can J Kidney Health Dis., 5: 2054358118778573. doi: 10.1177/2054358118778573. |
[14] | Te Riele AS, Tandri H, Bluemke DA (2014). Arrhythmogenic right ventricular cardiomyopathy (ARVC): cardiovascular magnetic resonance update. Journal of cardiovascular magnetic resonance: official journal of the Society for cardiovascular Magnetic Resonance; 16: 50. |
[15] | Vogelsberge H, Mahrholdt H, Deluigi CC, et al (2008). Cardivascular magnetic resonance in clinically suspected cordial amyloidosis: noninvasive imaging compared to endomyocardial biopsy. Journal of the American collage of Cardiology: 1022-30. |
APA Style
Mostafa Fadel Sonbol, Mahmoud Ibrahim Elshamy, Anas Mohamed Sabry Elhadary. (2021). Role of Cardiac MRI in Assessment Non-Ischemic Cardiomyopathy. International Journal of Medical Imaging, 9(1), 72-78. https://doi.org/10.11648/j.ijmi.20210901.17
ACS Style
Mostafa Fadel Sonbol; Mahmoud Ibrahim Elshamy; Anas Mohamed Sabry Elhadary. Role of Cardiac MRI in Assessment Non-Ischemic Cardiomyopathy. Int. J. Med. Imaging 2021, 9(1), 72-78. doi: 10.11648/j.ijmi.20210901.17
AMA Style
Mostafa Fadel Sonbol, Mahmoud Ibrahim Elshamy, Anas Mohamed Sabry Elhadary. Role of Cardiac MRI in Assessment Non-Ischemic Cardiomyopathy. Int J Med Imaging. 2021;9(1):72-78. doi: 10.11648/j.ijmi.20210901.17
@article{10.11648/j.ijmi.20210901.17, author = {Mostafa Fadel Sonbol and Mahmoud Ibrahim Elshamy and Anas Mohamed Sabry Elhadary}, title = {Role of Cardiac MRI in Assessment Non-Ischemic Cardiomyopathy}, journal = {International Journal of Medical Imaging}, volume = {9}, number = {1}, pages = {72-78}, doi = {10.11648/j.ijmi.20210901.17}, url = {https://doi.org/10.11648/j.ijmi.20210901.17}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijmi.20210901.17}, abstract = {Background: cardiomyopathies include a broad spectrum of myocardial problems which can affect the heart either a primary disease process or as part of a systemic disorder, which may be complicated by heart failure or death. Objective: the aim of the study to identify the role of cardiac magnetic resonance imaging to diagnose the different various types of cardiomyopathy. Patients and Methods: this study included 50 patients with suspected different types of non-ischemic cardiomyopathies referred from outpatient clinic of Cardiology at Al-Hussein University hospital from November 2018 to July 2019. Results: all patients showed mild to moderate mitral regurge (100% of cases), tricuspid regurge was seen in 3 cases (75% of cases) and aortic regurge was seen in 4 cases (50% of cases). The most value of MRI study of these patients was to differentiate whether if heart failure is related to 1ry dilated cardiomyopathy or other causes such as ischemia as they have different management in each group. Conclusion: CMR is a valuable (minimally or non-invasive) imaging technique in patients with suspected or known to have non-ischemic cardiomyopathies. It helps to identify the underlying cause, prognosis and responsiveness to therapy and affect management as well follow-up and most recently as a preventive diagnostic tool.}, year = {2021} }
TY - JOUR T1 - Role of Cardiac MRI in Assessment Non-Ischemic Cardiomyopathy AU - Mostafa Fadel Sonbol AU - Mahmoud Ibrahim Elshamy AU - Anas Mohamed Sabry Elhadary Y1 - 2021/03/03 PY - 2021 N1 - https://doi.org/10.11648/j.ijmi.20210901.17 DO - 10.11648/j.ijmi.20210901.17 T2 - International Journal of Medical Imaging JF - International Journal of Medical Imaging JO - International Journal of Medical Imaging SP - 72 EP - 78 PB - Science Publishing Group SN - 2330-832X UR - https://doi.org/10.11648/j.ijmi.20210901.17 AB - Background: cardiomyopathies include a broad spectrum of myocardial problems which can affect the heart either a primary disease process or as part of a systemic disorder, which may be complicated by heart failure or death. Objective: the aim of the study to identify the role of cardiac magnetic resonance imaging to diagnose the different various types of cardiomyopathy. Patients and Methods: this study included 50 patients with suspected different types of non-ischemic cardiomyopathies referred from outpatient clinic of Cardiology at Al-Hussein University hospital from November 2018 to July 2019. Results: all patients showed mild to moderate mitral regurge (100% of cases), tricuspid regurge was seen in 3 cases (75% of cases) and aortic regurge was seen in 4 cases (50% of cases). The most value of MRI study of these patients was to differentiate whether if heart failure is related to 1ry dilated cardiomyopathy or other causes such as ischemia as they have different management in each group. Conclusion: CMR is a valuable (minimally or non-invasive) imaging technique in patients with suspected or known to have non-ischemic cardiomyopathies. It helps to identify the underlying cause, prognosis and responsiveness to therapy and affect management as well follow-up and most recently as a preventive diagnostic tool. VL - 9 IS - 1 ER -